RIAZZINO, Switzerland — Linnea SA (“Linnea” or “the Company”), is proud to announce that it is celebrating the Company’s 40th anniversary in 2022. Linnea has been manufacturing high quality botanical ingredients at their GMP certified facility in Ticino, Switzerland since 1982.
Today Linnea produces a suite of natural beneficial botanical ingredients including: Bilberry, Ginkgo Biloba, Red Clover, 5 HTP, HMR Lignan™, Vinpocetine, Vincamine, Butylscopolamine and Cannabinoids.
Since 2016 Linnea has been focusing on producing valuable non-psychoactive cannabinoids. Linnea Cannabinoids delivers innovative trustworthy CBD ingredients for the pharmaceutical, dietary ingredients and cosmetics industries. Their CBD is available as a GMP-certified full spectrum extract and a 99% pure isolate. It is rare to find a company in the cannabinoid industry producing GMP-certified pharmaceutical-grade products with decades of experience.
Linnea’s newest product is a standardized full spectrum CBG (Cannabigerol) extract which is available for the food and cosmetics market.
“We are thrilled to be celebrating our 40 year anniversary and it is due to this experience that we are proud to have been able to create some of the only GMP certified pharmaceutical grade cannabinoid ingredients for companies to use in their product formulations. We believe quality and high standards are vital for cannabis companies and consumers,” said Susanne Caspar, the CEO of Linnea.
Linnea’s mission since its founding has been to improve people’s lives with high-quality standardized products, and they continue to live by this mission today. The company is constantly innovating new products and investing in sustainability projects.
Linnea has been providing gold-standard botanical ingredients for use in the pharmaceutical, cosmetics and dietary supplement industries for 40 years. Having expanded into the cannabis and cannabinoid industries in 2016, they helped pave the way in research, standardization and a pharmaceutical level of quality for this emerging global industry.
- Commentary: It’s time for Biden to keep his promises on cannabisPaul Armentano, the deputy director of the National Organization for the Reform of Marijuana Laws (NORML), calls on President Joe Biden to live up to the pledges made during his campaign regarding cannabis legalization.
- Unofficial totals show Missouri cannabis legalization initiative shortAn initiative to legalize recreational marijuana use in Missouri will need help if it is going to be on the November ballot. Reports from every county in the state show the petition is short of its goal in two of the six congressional districts needed to qualify for the ballot.
- Fate of Missouri cannabis initiative unclear as signature count continuesWhether Missouri voters will get a chance to legalize recreational marijuana in November is still in question. The latest incomplete tabulations show the Legal Missouri 2022 initiative is short of the necessary signatures in four of the six Congressional districts necessary to make the ballot.
- ACLU of NV suit to deschedule cannabis statewide survives challengeA legal effort by the ACLU of Nevada to force the Nevada Board of Pharmacy to remove cannabis from its Schedule 1 of controlled substances will proceed, Clark County Judge Joe Hardy ruled Wednesday when he denied the board’s motion to dismiss the ACLU’s lawsuit.
- Advocates, parents ‘beg’ Nebraskans to seek out and sign petition to legalize medical cannabisAdvocates for legalizing medical marijuana switched Wednesday from urging Nebraskans to sign their petition to begging them as a July 7 deadline looms to submit signatures to qualify for the ballot in November.
- Iowans launch cannabis reform campaign aimed at showing public supportRobert “Lewy” Lewis of Windsor Heights has been in pain since 1974, when he had spinal surgery at the age of 21. To repair a blockage in his spine, surgeons removed eight inches of his vertebrae and then sewed them back on, using about 300 steel stitches.
- Big Apple Cannabis: CWCB Returns to New York City for Eighth Year“No one seems to have gotten it right.” Mayor Eric Adams told a Friday afternoon crowd, of legal cannabis in America. “This is our chance to get it right.” New York City’s mayor addressed attendees of the 2022 Cannabis World Congress & Business Expo (CWCBExpo) on the second day of the three-day event. Adams stressed the social equity focus of New York’s cannabis program.
- Nebraska medical cannabis backers file legal challenge to petition processSupporters of medical marijuana in Nebraska have launched a legal challenge to the state’s requirement that 5% of registered voters in at least 38 counties sign a petition to get the measure before voters on the ballot.
- N.J. lawmakers seek to curb cannabis useAs New Jersey nears the end of its first month of legal recreational marijuana sales, lawmakers have introduced a series of bills aimed at restricting what types of workers can use cannabis off the job.
- Missouri House votes to require disclosure of medical cannabis ownership recordsThe Missouri House voted overwhelmingly Tuesday to require state regulators to disclose ownership information for businesses granted medical marijuana licenses that the state has withheld from public view.